The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema
Date
2021Author
Cicinelli, M.V.
Rosenblatt, A.
Grosso, D.
Zollet, P.
Capone, L.
Rabiolo, A.
Lattanzio, R.
Loewenstein, A.
Bandello, F.
Nassisi, M.
Tan, A.
Metadata
Show full item recordAbstract
Background/Objectives: To investigate if the visual and anatomic response to the first dexamethasone implant (DEX) predicts the 12-month clinical outcome after shifting to fluocinolone acetonide (FAc) implant in patients with diabetic macular oedema (DMO)

DSpace@İYYU by Istanbul Yeni Yüzyil University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..